<!--The Official Report of Parliamentary Debates (Hansard) of the Legislative Council and the House of Assembly of the Parliament of South Australia are covered by parliamentary privilege. Republication by others is not afforded the same protection and may result in exposure to legal liability if the material is defamatory. You may copy and make use of excerpts of proceedings where (1) you attribute the Parliament as the source, (2) you assume the risk of liability if the manner of your use is defamatory, (3) you do not use the material for the purpose of advertising, satire or ridicule, or to misrepresent members of Parliament, and (4) your use of the extracts is fair, accurate and not misleading. Copyright in the Official Report of Parliamentary Debates is held by the Attorney-General of South Australia.-->
<hansard id="" tocId="" xml:lang="EN-AU" schemaVersion="1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xml="http://www.w3.org/XML/1998/namespace" xmlns:xsi="http://www.w3.org/2007/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:noNamespaceSchemaLocation="hansard_1_0.xsd">
  <name>Legislative Council</name>
  <date date="2020-10-13" />
  <sessionName>Fifty-Fourth Parliament, Second Session (54-2)</sessionName>
  <parliamentNum>54</parliamentNum>
  <sessionNum>2</sessionNum>
  <parliamentName>Parliament of South Australia</parliamentName>
  <house>Legislative Council</house>
  <venue></venue>
  <reviewStage>published</reviewStage>
  <startPage num="1847" />
  <endPage num="1895" />
  <dateModified time="2022-08-06T14:30:00+00:00" />
  <proceeding continued="true">
    <name>Question Time</name>
    <subject>
      <name>National Immunisation Program</name>
      <text id="20201013eb88087875764653b0000234">
        <heading>National Immunisation Program</heading>
      </text>
      <talker role="member" id="3404" kind="question">
        <name>The Hon. J.A. DARLEY</name>
        <house>Legislative Council</house>
        <questions>
          <question date="2020-10-13">
            <name>National Immunisation Program</name>
          </question>
        </questions>
        <startTime time="2020-10-13T14:53:33" />
        <text id="20201013eb88087875764653b0000235">
          <timeStamp time="2020-10-13T14:53:33" />
          <by role="member" id="3404">The Hon. J.A. DARLEY (14:53):</by>  Does the minister have an approximate idea as to when a decision will be made on that review?</text>
      </talker>
      <talker role="member" id="3164" kind="answer">
        <name>The Hon. S.G. WADE</name>
        <house>Legislative Council</house>
        <portfolios>
          <portfolio id="">
            <name>Minister for Health and Wellbeing</name>
          </portfolio>
        </portfolios>
        <questions>
          <question date="2020-10-13">
            <name>National Immunisation Program</name>
          </question>
        </questions>
        <startTime time="2020-10-13T14:53:42" />
        <page num="1856" />
        <text id="20201013eb88087875764653b0000236">
          <timeStamp time="2020-10-13T14:53:42" />
          <by role="member" id="3164">The Hon. S.G. WADE (Minister for Health and Wellbeing) (14:53):</by>  Just to clarify, it is a review to government, so then once the review is received we would have to consider the recommendations. If I can take the opportunity to unpack the honourable member's question slightly more, the challenges of the influenza vaccination program and other vaccination programs in 2020 will need to be considered in the context of the COVID vaccine. If indeed we have a COVID vaccine, it will be putting pressure on our distribution networks that we would otherwise be using for those other immunisation programs.</text>
        <text id="20201013eb88087875764653b0000237">I would like to pay tribute to the federal government. The work they have done to secure COVID vaccine supplies is commendable. I am also grateful that the Hon. Greg Hunt, the federal minister, and his department have already engaged the states and territories to start planning for vaccine distribution. We are very appreciative of the leadership that they are providing in that regard, but it will not be without challenge, not only for the commonwealth but certainly for each state and territory government and our partners, such as community pharmacists. These are challenges that we will need to face together.</text>
      </talker>
    </subject>
  </proceeding>
</hansard>